Covid-19 Impact on Specialty Generics Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Specialty Generics, including the following market information:
Major competitors identified in this market include Teva Pharmaceuticals USA, Inc., Mylan N.V., Sandoz International GmbH, Akorn, Inc., Mallinckrodt, Valeant Pharmaceuticals International, Inc., Pfizer Inc., Endo Pharmaceuticals Inc., Apotex Corp., Sun Pharmaceutical Industries Ltd., etc.
Based on the Region:
- Global Specialty Generics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Specialty Generics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Specialty Generics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Specialty Generics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Teva Pharmaceuticals USA, Inc., Mylan N.V., Sandoz International GmbH, Akorn, Inc., Mallinckrodt, Valeant Pharmaceuticals International, Inc., Pfizer Inc., Endo Pharmaceuticals Inc., Apotex Corp., Sun Pharmaceutical Industries Ltd., etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Injectables
- Oral
- Others
- Oncology
- Inflammatory Conditions
- Multiple Sclerosis
- Hepatitis C
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Specialty Generics Industry
1.7 COVID-19 Impact: Specialty Generics Market Trends
2 GLOBAL SPECIALTY GENERICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Specialty Generics Business Impact Assessment - COVID-19
2.1.1 Global Specialty Generics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Specialty Generics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Specialty Generics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Specialty Generics Headquarters and Area Served
3.3 Date of Key Players Enter into Specialty Generics Market
3.4 Key Players Specialty Generics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON SPECIALTY GENERICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Injectables
1.4.2 Oral
1.4.3 Others
4.2 By Type, Global Specialty Generics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON SPECIALTY GENERICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Oncology
5.5.2 Inflammatory Conditions
5.5.3 Multiple Sclerosis
5.5.4 Hepatitis C
5.2 By Application, Global Specialty Generics Market Size, 2019-2021
5.2.1 By Application, Global Specialty Generics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Teva Pharmaceuticals USA, Inc.
7.1.1 Teva Pharmaceuticals USA, Inc. Business Overview
7.1.2 Teva Pharmaceuticals USA, Inc. Specialty Generics Quarterly Revenue, 2020
7.1.3 Teva Pharmaceuticals USA, Inc. Specialty Generics Product Introduction
7.1.4 Teva Pharmaceuticals USA, Inc. Response to COVID-19 and Related Developments
7.2 Mylan N.V.
7.2.1 Mylan N.V. Business Overview
7.2.2 Mylan N.V. Specialty Generics Quarterly Revenue, 2020
7.2.3 Mylan N.V. Specialty Generics Product Introduction
7.2.4 Mylan N.V. Response to COVID-19 and Related Developments
7.3 Sandoz International GmbH
7.3.1 Sandoz International GmbH Business Overview
7.3.2 Sandoz International GmbH Specialty Generics Quarterly Revenue, 2020
7.3.3 Sandoz International GmbH Specialty Generics Product Introduction
7.3.4 Sandoz International GmbH Response to COVID-19 and Related Developments
7.4 Akorn, Inc.
7.4.1 Akorn, Inc. Business Overview
7.4.2 Akorn, Inc. Specialty Generics Quarterly Revenue, 2020
7.4.3 Akorn, Inc. Specialty Generics Product Introduction
7.4.4 Akorn, Inc. Response to COVID-19 and Related Developments
7.5 Mallinckrodt
7.5.1 Mallinckrodt Business Overview
7.5.2 Mallinckrodt Specialty Generics Quarterly Revenue, 2020
7.5.3 Mallinckrodt Specialty Generics Product Introduction
7.5.4 Mallinckrodt Response to COVID-19 and Related Developments
7.6 Valeant Pharmaceuticals International, Inc.
7.6.1 Valeant Pharmaceuticals International, Inc. Business Overview
7.6.2 Valeant Pharmaceuticals International, Inc. Specialty Generics Quarterly Revenue, 2020
7.6.3 Valeant Pharmaceuticals International, Inc. Specialty Generics Product Introduction
7.6.4 Valeant Pharmaceuticals International, Inc. Response to COVID-19 and Related Developments
7.7 Pfizer Inc.
7.7.1 Pfizer Inc. Business Overview
7.7.2 Pfizer Inc. Specialty Generics Quarterly Revenue, 2020
7.7.3 Pfizer Inc. Specialty Generics Product Introduction
7.7.4 Pfizer Inc. Response to COVID-19 and Related Developments
7.8 Endo Pharmaceuticals Inc.
7.8.1 Endo Pharmaceuticals Inc. Business Overview
7.8.2 Endo Pharmaceuticals Inc. Specialty Generics Quarterly Revenue, 2020
7.8.3 Endo Pharmaceuticals Inc. Specialty Generics Product Introduction
7.8.4 Endo Pharmaceuticals Inc. Response to COVID-19 and Related Developments
7.9 Apotex Corp.
7.9.1 Apotex Corp. Business Overview
7.9.2 Apotex Corp. Specialty Generics Quarterly Revenue, 2020
7.9.3 Apotex Corp. Specialty Generics Product Introduction
7.9.4 Apotex Corp. Response to COVID-19 and Related Developments
7.10 Sun Pharmaceutical Industries Ltd.
7.10.1 Sun Pharmaceutical Industries Ltd. Business Overview
7.10.2 Sun Pharmaceutical Industries Ltd. Specialty Generics Quarterly Revenue, 2020
7.10.3 Sun Pharmaceutical Industries Ltd. Specialty Generics Product Introduction
7.10.4 Sun Pharmaceutical Industries Ltd. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Specialty Generics Industry
1.7 COVID-19 Impact: Specialty Generics Market Trends
2 GLOBAL SPECIALTY GENERICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Specialty Generics Business Impact Assessment - COVID-19
2.1.1 Global Specialty Generics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Specialty Generics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Specialty Generics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Specialty Generics Headquarters and Area Served
3.3 Date of Key Players Enter into Specialty Generics Market
3.4 Key Players Specialty Generics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON SPECIALTY GENERICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Injectables
1.4.2 Oral
1.4.3 Others
4.2 By Type, Global Specialty Generics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON SPECIALTY GENERICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Oncology
5.5.2 Inflammatory Conditions
5.5.3 Multiple Sclerosis
5.5.4 Hepatitis C
5.2 By Application, Global Specialty Generics Market Size, 2019-2021
5.2.1 By Application, Global Specialty Generics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Teva Pharmaceuticals USA, Inc.
7.1.1 Teva Pharmaceuticals USA, Inc. Business Overview
7.1.2 Teva Pharmaceuticals USA, Inc. Specialty Generics Quarterly Revenue, 2020
7.1.3 Teva Pharmaceuticals USA, Inc. Specialty Generics Product Introduction
7.1.4 Teva Pharmaceuticals USA, Inc. Response to COVID-19 and Related Developments
7.2 Mylan N.V.
7.2.1 Mylan N.V. Business Overview
7.2.2 Mylan N.V. Specialty Generics Quarterly Revenue, 2020
7.2.3 Mylan N.V. Specialty Generics Product Introduction
7.2.4 Mylan N.V. Response to COVID-19 and Related Developments
7.3 Sandoz International GmbH
7.3.1 Sandoz International GmbH Business Overview
7.3.2 Sandoz International GmbH Specialty Generics Quarterly Revenue, 2020
7.3.3 Sandoz International GmbH Specialty Generics Product Introduction
7.3.4 Sandoz International GmbH Response to COVID-19 and Related Developments
7.4 Akorn, Inc.
7.4.1 Akorn, Inc. Business Overview
7.4.2 Akorn, Inc. Specialty Generics Quarterly Revenue, 2020
7.4.3 Akorn, Inc. Specialty Generics Product Introduction
7.4.4 Akorn, Inc. Response to COVID-19 and Related Developments
7.5 Mallinckrodt
7.5.1 Mallinckrodt Business Overview
7.5.2 Mallinckrodt Specialty Generics Quarterly Revenue, 2020
7.5.3 Mallinckrodt Specialty Generics Product Introduction
7.5.4 Mallinckrodt Response to COVID-19 and Related Developments
7.6 Valeant Pharmaceuticals International, Inc.
7.6.1 Valeant Pharmaceuticals International, Inc. Business Overview
7.6.2 Valeant Pharmaceuticals International, Inc. Specialty Generics Quarterly Revenue, 2020
7.6.3 Valeant Pharmaceuticals International, Inc. Specialty Generics Product Introduction
7.6.4 Valeant Pharmaceuticals International, Inc. Response to COVID-19 and Related Developments
7.7 Pfizer Inc.
7.7.1 Pfizer Inc. Business Overview
7.7.2 Pfizer Inc. Specialty Generics Quarterly Revenue, 2020
7.7.3 Pfizer Inc. Specialty Generics Product Introduction
7.7.4 Pfizer Inc. Response to COVID-19 and Related Developments
7.8 Endo Pharmaceuticals Inc.
7.8.1 Endo Pharmaceuticals Inc. Business Overview
7.8.2 Endo Pharmaceuticals Inc. Specialty Generics Quarterly Revenue, 2020
7.8.3 Endo Pharmaceuticals Inc. Specialty Generics Product Introduction
7.8.4 Endo Pharmaceuticals Inc. Response to COVID-19 and Related Developments
7.9 Apotex Corp.
7.9.1 Apotex Corp. Business Overview
7.9.2 Apotex Corp. Specialty Generics Quarterly Revenue, 2020
7.9.3 Apotex Corp. Specialty Generics Product Introduction
7.9.4 Apotex Corp. Response to COVID-19 and Related Developments
7.10 Sun Pharmaceutical Industries Ltd.
7.10.1 Sun Pharmaceutical Industries Ltd. Business Overview
7.10.2 Sun Pharmaceutical Industries Ltd. Specialty Generics Quarterly Revenue, 2020
7.10.3 Sun Pharmaceutical Industries Ltd. Specialty Generics Product Introduction
7.10.4 Sun Pharmaceutical Industries Ltd. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Specialty Generics Assessment
Table 9. COVID-19 Impact: Specialty Generics Market Trends
Table 10. COVID-19 Impact Global Specialty Generics Market Size
Table 11. Global Specialty Generics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Specialty Generics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Specialty Generics Market Growth Drivers
Table 14. Global Specialty Generics Market Restraints
Table 15. Global Specialty Generics Market Opportunities
Table 16. Global Specialty Generics Market Challenges
Table 17. By Players, Specialty Generics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Specialty Generics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Specialty Generics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Specialty Generics Market
Table 21. Key Players Specialty Generics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Specialty Generics Market Size 2019-2021, (US$ Million)
Table 24. Global Specialty Generics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Specialty Generics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 57. Teva Pharmaceuticals USA, Inc. Business Overview
Table 58. Teva Pharmaceuticals USA, Inc. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Teva Pharmaceuticals USA, Inc. Specialty Generics Product
Table 60. Teva Pharmaceuticals USA, Inc. Response to COVID-19 and Related Developments
Table 61. Mylan N.V. Business Overview
Table 62. Mylan N.V. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Mylan N.V. Specialty Generics Product
Table 64. Mylan N.V. Response to COVID-19 and Related Developments
Table 65. Sandoz International GmbH Business Overview
Table 66. Sandoz International GmbH Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Sandoz International GmbH Specialty Generics Product
Table 68. Sandoz International GmbH Response to COVID-19 and Related Developments
Table 69. Akorn, Inc. Business Overview
Table 70. Akorn, Inc. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Akorn, Inc. Specialty Generics Product
Table 72. Akorn, Inc. Response to COVID-19 and Related Developments
Table 73. Mallinckrodt Business Overview
Table 74. Mallinckrodt Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Mallinckrodt Specialty Generics Product
Table 76. Mallinckrodt Response to COVID-19 and Related Developments
Table 77. Valeant Pharmaceuticals International, Inc. Business Overview
Table 78. Valeant Pharmaceuticals International, Inc. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Valeant Pharmaceuticals International, Inc. Specialty Generics Product
Table 80. Valeant Pharmaceuticals International, Inc. Response to COVID-19 and Related Developments
Table 81. Pfizer Inc. Business Overview
Table 82. Pfizer Inc. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Pfizer Inc. Specialty Generics Product
Table 84. Pfizer Inc. Response to COVID-19 and Related Developments
Table 85. Endo Pharmaceuticals Inc. Business Overview
Table 86. Endo Pharmaceuticals Inc. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Endo Pharmaceuticals Inc. Specialty Generics Product
Table 88. Endo Pharmaceuticals Inc. Response to COVID-19 and Related Developments
Table 89. Apotex Corp. Business Overview
Table 90. Apotex Corp. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Apotex Corp. Specialty Generics Product
Table 92. Apotex Corp. Response to COVID-19 and Related Developments
Table 93. Sun Pharmaceutical Industries Ltd. Business Overview
Table 94. Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sun Pharmaceutical Industries Ltd. Specialty Generics Product
Table 96. Sun Pharmaceutical Industries Ltd. Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Specialty Generics Assessment
Table 9. COVID-19 Impact: Specialty Generics Market Trends
Table 10. COVID-19 Impact Global Specialty Generics Market Size
Table 11. Global Specialty Generics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Specialty Generics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Specialty Generics Market Growth Drivers
Table 14. Global Specialty Generics Market Restraints
Table 15. Global Specialty Generics Market Opportunities
Table 16. Global Specialty Generics Market Challenges
Table 17. By Players, Specialty Generics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Specialty Generics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Specialty Generics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Specialty Generics Market
Table 21. Key Players Specialty Generics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Specialty Generics Market Size 2019-2021, (US$ Million)
Table 24. Global Specialty Generics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Specialty Generics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Specialty Generics Market Size, 2019-2021 (US$ Million)
Table 57. Teva Pharmaceuticals USA, Inc. Business Overview
Table 58. Teva Pharmaceuticals USA, Inc. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Teva Pharmaceuticals USA, Inc. Specialty Generics Product
Table 60. Teva Pharmaceuticals USA, Inc. Response to COVID-19 and Related Developments
Table 61. Mylan N.V. Business Overview
Table 62. Mylan N.V. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Mylan N.V. Specialty Generics Product
Table 64. Mylan N.V. Response to COVID-19 and Related Developments
Table 65. Sandoz International GmbH Business Overview
Table 66. Sandoz International GmbH Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Sandoz International GmbH Specialty Generics Product
Table 68. Sandoz International GmbH Response to COVID-19 and Related Developments
Table 69. Akorn, Inc. Business Overview
Table 70. Akorn, Inc. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Akorn, Inc. Specialty Generics Product
Table 72. Akorn, Inc. Response to COVID-19 and Related Developments
Table 73. Mallinckrodt Business Overview
Table 74. Mallinckrodt Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Mallinckrodt Specialty Generics Product
Table 76. Mallinckrodt Response to COVID-19 and Related Developments
Table 77. Valeant Pharmaceuticals International, Inc. Business Overview
Table 78. Valeant Pharmaceuticals International, Inc. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Valeant Pharmaceuticals International, Inc. Specialty Generics Product
Table 80. Valeant Pharmaceuticals International, Inc. Response to COVID-19 and Related Developments
Table 81. Pfizer Inc. Business Overview
Table 82. Pfizer Inc. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Pfizer Inc. Specialty Generics Product
Table 84. Pfizer Inc. Response to COVID-19 and Related Developments
Table 85. Endo Pharmaceuticals Inc. Business Overview
Table 86. Endo Pharmaceuticals Inc. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Endo Pharmaceuticals Inc. Specialty Generics Product
Table 88. Endo Pharmaceuticals Inc. Response to COVID-19 and Related Developments
Table 89. Apotex Corp. Business Overview
Table 90. Apotex Corp. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Apotex Corp. Specialty Generics Product
Table 92. Apotex Corp. Response to COVID-19 and Related Developments
Table 93. Sun Pharmaceutical Industries Ltd. Business Overview
Table 94. Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sun Pharmaceutical Industries Ltd. Specialty Generics Product
Table 96. Sun Pharmaceutical Industries Ltd. Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Specialty Generics Product Picture
Figure 2. Specialty Generics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Specialty Generics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Specialty Generics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Specialty Generics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Specialty Generics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Specialty Generics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Specialty Generics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Specialty Generics Market Size Market Share, 2019-2021
Figure 1. Specialty Generics Product Picture
Figure 2. Specialty Generics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Specialty Generics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Specialty Generics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Specialty Generics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Specialty Generics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Specialty Generics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Specialty Generics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Specialty Generics Market Size Market Share, 2019-2021
